dihydrotestosterone has been researched along with Hyperandrogenism in 41 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (4.88) | 18.2507 |
2000's | 7 (17.07) | 29.6817 |
2010's | 17 (41.46) | 24.3611 |
2020's | 15 (36.59) | 2.80 |
Authors | Studies |
---|---|
Campbell, RE; Coyle, CS; Handelsman, DJ; Prescott, M; Walters, KA | 1 |
Cochran, BJ; Edwards, MC; Gilchrist, RB; Handelsman, DJ; Hu, Y; Ledger, WL; Padmanabhan, V; Rodriguez Paris, V; Rye, KA; Walters, KA; Xiong, T | 1 |
Divall, S; Feng, M; Fu, X; Jones, D; Ubba, V; Wang, H; Wu, S; Yang, L; Yang, X | 1 |
Aflatounian, A; Bertoldo, MJ; Cochran, BJ; Edwards, MC; Gilchrist, RB; Ledger, WL; Paris, VR; Richani, D; Walters, KA; Wu, LE | 1 |
Djordjevic, A; Ignjatović, Đ; Macut, D; Mićić, B; Tomić, M; Tovilović-Kovačević, G; Vojnović Milutinović, D | 1 |
Andreeva, EN; Bondarenko, IZ; Filatova, VA; Ioutsi, VA; Mel'nichenko, GA; Mokrysheva, NG; Rozhivanov, RV | 1 |
Billig, H; Brännström, M; Hu, M; Huang, X; Li, Y; Lu, Y; Sferruzzi-Perri, AN; Shao, LR; Zhang, X; Zhang, Y | 1 |
He, JJ; Jing, YX; Li, HX; Li, YM; Yu, X; Yue, F; Zhang, XH | 1 |
Ahima, R; Awe, O; Feng, M; Ma, Y; Segars, J; Shen, M; Wang, Z; Wolfe, A; Wu, S; Xue, P | 1 |
Gopalakrishnan, V; Krishnan, A; Muthusami, S; Periyasamy, L; Ramachandran, I; Stanley, JA | 1 |
Bar-Joseph, H; Ben-Ami, I; Miller, I; Nemerovsky, L; Shalgi, R | 1 |
Aflatounian, A; Anderson, RA; Begg, DP; Bertoldo, MJ; Campbell, RE; Edwards, MC; Gilchrist, RB; Handelsman, DJ; Nagarkar, R; Padmanabhan, V; Rodriguez Paris, V; Sucquart, IE; Walters, KA | 1 |
Davenport, K; Everman, SJ; Logan, MK; Pruett, JE; Romero, DG; Torres Fernandez, ED; Vinson, RM; Yanes Cardozo, LL; Ye, SA | 1 |
Basnet, J; Huffman, AM; Rezq, S; Romero, DG; Yanes Cardozo, LL | 1 |
Filatova, VA; Rozhivanov, RV | 1 |
Billig, H; Brännström, M; Hu, M; Ma, S; Sferruzzi-Perri, AN; Shao, LR; Wang, X; Wu, X; Yang, F; Zhang, D; Zhang, Y | 1 |
Chen, ZJ; Fan, HY; Ji, SY; Li, BT; Liu, HB; Liu, J; Liu, XM; Zhang, YC; Zhang, YL | 1 |
Andrisse, S; Billings, K; Wu, S; Xue, P | 1 |
Chen, YA; Cheung, A; Leader, A; Lima, PDA; Nivet, AL; Tsang, BK; Tzeng, CR; Wang, Q | 1 |
Moulana, M | 1 |
Candelaria, NR; Ljungberg, MC; McAllister, JM; Padmanabhan, A; Pew, BK; Richards, JS; Rossano, AM; Shelly, KE; Solis, M; Stossi, F; Wu, S | 1 |
Li, MX; Sun, LF; Xiao, TX; Yang, YL; Zhang, JV | 1 |
Billig, H; Brännström, M; Cui, P; Guo, X; Han, Y; Hu, M; Jia, W; Lager, S; Li, J; Li, W; Liu, G; Sferruzzi-Perri, AN; Shao, LR; Wu, XK; Xu, H; Zhang, Y; Zhao, W | 1 |
Bui, E; do Carmo, JM; Granger, JP; Hall, JE; Lima, R; Maranon, R; Moulana, M; Reckelhoff, JF; Smith, AD; Spradley, FT; Thomas, RL; Zhang, H | 1 |
Casson, P; Hurliman, A; Keller Brown, J; Maille, N; Mandala, M; Osol, G | 1 |
da Silva, AA; do Carmo, JM; Hall, JE; Houghton, HJ; Moak, SP; Smith, A | 1 |
Dalmasso, C; Maranon, R; Moulana, M; Patil, C; Reckelhoff, JF; Romero, DG | 1 |
Andrisse, S; Billings, K; Chen, Y; Childress, S; Ma, Y; Sonko, ML; Stewart, A; Wolfe, A; Wu, S; Xue, P | 1 |
Cabri, P; De Sutter, P; Deforce, D; Dhont, M; Stoop, D; Van Nieuwerburgh, F | 1 |
Ding, GL; Dong, MY; Huang, HF; Lu, XE; Lv, PP; Qu, F; Sheng, JZ; Shi, BW; Wang, FF; Zhang, D | 1 |
Hedayati, M; Naghii, MR | 1 |
Ding, GL; El-Prince, M; Gao, Q; Huang, HF; Huang, YT; Jin, M; Leung, PC; Pan, HH; Qu, F; Sheng, JZ; Shi, BW; Wang, FF; Yin, R | 1 |
Liu, JY; Murphy, BD; Tsang, BK; Xue, K | 1 |
Klimova, OP | 1 |
Tomboc, M; Witchel, SF | 1 |
Marouliss, GB; Triantafillidis, IK | 1 |
Stanczyk, FZ | 1 |
Beckmann, MW; Binder, H; Cupisti, S; Dittrich, R; Hoffmann, I; Kiesewetter, F; Mueller, A | 1 |
Rittmaster, RS | 1 |
Korsić, M | 1 |
Litvinova, LB | 1 |
3 review(s) available for dihydrotestosterone and Hyperandrogenism
Article | Year |
---|---|
Polycystic ovarian disease: the adrenal connection.
Topics: Adrenal Glands; Androstenedione; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Dexamethasone; Dihydrotestosterone; Female; Glucocorticoids; Humans; Hyperandrogenism; Polycystic Ovary Syndrome; Testosterone | 2006 |
Diagnosis of hyperandrogenism: biochemical criteria.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Acne Vulgaris; Alopecia; Ammonium Sulfate; Androgens; Androstenedione; Chemical Precipitation; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Dialysis; Dihydrotestosterone; Female; Gas Chromatography-Mass Spectrometry; Hair Follicle; Hirsutism; Humans; Hyperandrogenism; Radioimmunoassay; Reference Values; Testosterone | 2006 |
Clinical relevance of testosterone and dihydrotestosterone metabolism in women.
Topics: Cholestenone 5 alpha-Reductase; Dihydrotestosterone; Female; Humans; Hyperandrogenism; Oxidoreductases; Testosterone | 1995 |
38 other study(ies) available for dihydrotestosterone and Hyperandrogenism
Article | Year |
---|---|
Chronic androgen excess in female mice does not impact luteinizing hormone pulse frequency or putative GABAergic inputs to GnRH neurons.
Topics: Androgens; Animals; Dihydrotestosterone; Female; Gonadotropin-Releasing Hormone; Humans; Hyperandrogenism; Luteinizing Hormone; Male; Mice; Neurons; Polycystic Ovary Syndrome; Pregnancy; Prenatal Exposure Delayed Effects | 2022 |
Androgen signaling in adipose tissue, but less likely skeletal muscle, mediates development of metabolic traits in a PCOS mouse model.
Topics: Adipose Tissue; Adipose Tissue, Brown; Androgens; Animals; Dihydrotestosterone; Disease Models, Animal; Female; Hyperandrogenism; Mice; Muscle, Skeletal; Phenotype; Polycystic Ovary Syndrome; Receptors, Androgen | 2022 |
Comparison of Reproductive Function Between Normal and Hyperandrogenemia Conditions in Female Mice With Deletion of Hepatic Androgen Receptor.
Topics: Animals; Dihydrotestosterone; Female; Glucose; Humans; Hyperandrogenism; Liver; Mice; Obesity; Polycystic Ovary Syndrome; Receptors, Androgen; Reproduction | 2022 |
Declining muscle NAD
Topics: Animals; Dihydrotestosterone; Female; Humans; Hyperandrogenism; Insulin Resistance; Lipids; Metabolic Syndrome; Mice; Muscle, Skeletal; NAD; Nicotinamide Mononucleotide; Obesity; Polycystic Ovary Syndrome | 2022 |
Effects of early life overnutrition and hyperandrogenism on spatial learning and memory in a rat model of polycystic ovary syndrome.
Topics: Animals; Dihydrotestosterone; Disease Models, Animal; Female; Humans; Hyperandrogenism; Insulin; Insulin Resistance; Obesity; Polycystic Ovary Syndrome; Rats; Spatial Learning | 2023 |
[Features of steroidogenesis and arterial hypertension in men in different types of "physiological" male hyperandrogenism].
Topics: 17-alpha-Hydroxypregnenolone; 17-alpha-Hydroxyprogesterone; Androstenedione; Dihydrotestosterone; Estradiol; Female; Humans; Hyperandrogenism; Hypertension; Male; Ovarian Diseases; Testosterone | 2023 |
Defective Uterine Spiral Artery Remodeling and Placental Senescence in a Pregnant Rat Model of Polycystic Ovary Syndrome.
Topics: Animals; Arteries; Dihydrotestosterone; Female; Humans; Hyperandrogenism; Insulin; Placenta; Polycystic Ovary Syndrome; Pregnancy; Rats; Uterine Artery; Uterus | 2023 |
N6-methyladenosine demethylase FTO related to hyperandrogenism in PCOS via AKT pathway.
Topics: Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Androgens; Animals; Dihydrotestosterone; Female; Granulosa Cells; Humans; Hyperandrogenism; Ligases; Polycystic Ovary Syndrome; Prostate-Specific Antigen; Proto-Oncogene Proteins c-akt; Rats | 2023 |
Gonadotrope androgen receptor mediates pituitary responsiveness to hormones and androgen-induced subfertility.
Topics: Animals; Calcium Signaling; Cells, Cultured; Dihydrotestosterone; Disease Models, Animal; Drug Implants; Estrous Cycle; Female; Gonadotrophs; Gonadotropin-Releasing Hormone; Humans; Hyperandrogenism; Hypothalamo-Hypophyseal System; Infertility; Luteinizing Hormone; Mice; Mice, Transgenic; Monomeric GTP-Binding Proteins; Ovary; Primary Cell Culture; Receptors, Androgen; Up-Regulation | 2019 |
Effect of DHT-Induced Hyperandrogenism on the Pro-Inflammatory Cytokines in a Rat Model of Polycystic Ovary Morphology.
Topics: Animals; Cytokines; Dihydrotestosterone; Disease Models, Animal; Female; Follicle Stimulating Hormone; Hyperandrogenism; Inflammation Mediators; Insulin; Liver; Luteinizing Hormone; Polycystic Ovary Syndrome; Rats; Rats, Wistar; Urocortins | 2020 |
Pigment epithelium-derived factor (PEDF) negates hyperandrogenic PCOS features.
Topics: Animals; Anti-Inflammatory Agents; Cell Line; Dihydrotestosterone; Disease Models, Animal; Eye Proteins; Female; Granulosa Cells; Humans; Hyperandrogenism; Mice; Nerve Growth Factors; Ovary; Polycystic Ovary Syndrome; Serpins; Signal Transduction | 2020 |
Neurokinin 3 Receptor Antagonism Ameliorates Key Metabolic Features in a Hyperandrogenic PCOS Mouse Model.
Topics: Androgens; Animals; Blood Glucose; Dihydrotestosterone; Disease Models, Animal; Female; Humans; Hyperandrogenism; Lectins; Membrane Proteins; Mice; Mice, Inbred C57BL; Polycystic Ovary Syndrome; Receptors, Neurokinin-3; Triglycerides | 2021 |
Impact of SGLT-2 Inhibition on Cardiometabolic Abnormalities in a Rat Model of Polycystic Ovary Syndrome.
Topics: Animals; Benzhydryl Compounds; Dihydrotestosterone; Disease Models, Animal; Female; Glucosides; Heart; Hyperandrogenism; Polycystic Ovary Syndrome; Proteins; Rats; Rats, Sprague-Dawley; RNA, Messenger; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors | 2021 |
SARS-CoV-2 Viral Entry Proteins in Hyperandrogenemic Female Mice: Implications for Women with PCOS and COVID-19.
Topics: Angiotensin-Converting Enzyme 2; Animals; Blood Glucose; Body Weight; Cathepsin L; COVID-19; Dihydrotestosterone; Female; Humans; Hyperandrogenism; Kidney; Mice; Mice, Inbred C57BL; Polycystic Ovary Syndrome; SARS-CoV-2; Serine Endopeptidases; Up-Regulation; Virus Internalization | 2021 |
[Features of hyperandrogenism in men].
Topics: Aged; Cross-Sectional Studies; Dihydrotestosterone; Humans; Hyperandrogenism; Male; Sex Hormone-Binding Globulin; Testosterone | 2021 |
Increased uterine androgen receptor protein abundance results in implantation and mitochondrial defects in pregnant rats with hyperandrogenism and insulin resistance.
Topics: Androgens; Animals; Decidua; Dihydrotestosterone; Embryo Implantation; Endometrium; Female; Hyperandrogenism; Insulin; Insulin Resistance; Male; Mitochondria; Polycystic Ovary Syndrome; Pregnancy; Rats; Rats, Sprague-Dawley; Receptors, Androgen; Uterus | 2021 |
The polycystic ovary syndrome-associated gene Yap1 is regulated by gonadotropins and sex steroid hormones in hyperandrogenism-induced oligo-ovulation in mouse.
Topics: Adaptor Proteins, Signal Transducing; Animals; Cell Cycle Proteins; Cell Proliferation; Chorionic Gonadotropin; Dihydrotestosterone; Disease Models, Animal; Female; Gene Expression Regulation; Gonadotropins, Equine; Granulosa Cells; Horses; Humans; Hyperandrogenism; Luteinizing Hormone; Mice; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Ovary; Ovulation; Phosphoproteins; Polycystic Ovary Syndrome; Primary Cell Culture; Signal Transduction; YAP-Signaling Proteins | 2017 |
Insulin signaling displayed a differential tissue-specific response to low-dose dihydrotestosterone in female mice.
Topics: Animals; Dihydrotestosterone; Dose-Response Relationship, Drug; Energy Metabolism; Female; Hyperandrogenism; Insulin; Insulin Resistance; Mice; Mice, Inbred C57BL; Muscle, Skeletal; Organ Specificity; Ovary; Signal Transduction | 2018 |
Polycystic ovary syndrome: possible involvement of androgen-induced, chemerin-mediated ovarian recruitment of monocytes/macrophages.
Topics: Androgens; Animals; Apoptosis; Cell Movement; Chemokines; Dihydrotestosterone; Disease Models, Animal; Female; Granulosa Cells; Humans; Hyperandrogenism; Intercellular Signaling Peptides and Proteins; Macrophages; Monocytes; Ovary; Polycystic Ovary Syndrome; Rats; Rats, Sprague-Dawley; Receptors, Chemokine | 2018 |
Immunophenotypic profile of leukocytes in hyperandrogenemic female rat an animal model of polycystic ovary syndrome.
Topics: Animals; Dihydrotestosterone; Disease Models, Animal; Female; Hyperandrogenism; Immunophenotyping; Leukocytes; Phenotype; Polycystic Ovary Syndrome; Rats; Rats, Sprague-Dawley; T-Lymphocytes, Regulatory; Th17 Cells | 2019 |
VCAM1 Is Induced in Ovarian Theca and Stromal Cells in a Mouse Model of Androgen Excess.
Topics: Animals; COUP Transcription Factor II; Dihydrotestosterone; Female; Hyperandrogenism; Mice; Ovarian Follicle; Ovary; Receptors, Androgen; Stromal Cells; Theca Cells; Vascular Cell Adhesion Molecule-1 | 2019 |
Removal of DHT can relieve polycystic ovarian but not metabolic abnormalities in DHT-induced hyperandrogenism in mice.
Topics: Adipose Tissue; Animals; Dihydrotestosterone; Disease Models, Animal; Disease Progression; Female; Gene Expression; Hyperandrogenism; Metabolic Syndrome; Mice; Mice, Inbred C57BL; Ovary; Polycystic Ovary Syndrome; Stimulation, Chemical; Time Factors | 2019 |
Hyperandrogenism and insulin resistance-induced fetal loss: evidence for placental mitochondrial abnormalities and elevated reactive oxygen species production in pregnant rats that mimic the clinical features of polycystic ovary syndrome.
Topics: Abortion, Spontaneous; Animals; Dihydrotestosterone; Female; Glycogen; Hyperandrogenism; Insulin Resistance; Kelch-Like ECH-Associated Protein 1; Mitochondria; NF-E2-Related Factor 2; Polycystic Ovary Syndrome; Pregnancy; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Superoxide Dismutase-1; Trophoblasts | 2019 |
Roles for the sympathetic nervous system, renal nerves, and CNS melanocortin-4 receptor in the elevated blood pressure in hyperandrogenemic female rats.
Topics: Adrenergic Antagonists; Animals; Arterial Pressure; Dihydrotestosterone; Disease Models, Animal; Female; Hormone Antagonists; Hyperandrogenism; Hypertension; Hypothalamus; Kidney; Polycystic Ovary Syndrome; Rats, Sprague-Dawley; Receptor, Melanocortin, Type 4; Signal Transduction; Sympathectomy; Sympathetic Nervous System; Time Factors | 2015 |
Hyperandrogenism and Insulin Resistance, Not Changes in Body Weight, Mediate the Development of Endothelial Dysfunction in a Female Rat Model of Polycystic Ovary Syndrome (PCOS).
Topics: Androgen Antagonists; Androgens; Animals; Arteries; Blood Pressure; Body Weight; Dihydrotestosterone; Endothelium, Vascular; Female; Flutamide; Hyperandrogenism; Hypoglycemic Agents; Insulin Resistance; Metformin; Polycystic Ovary Syndrome; Random Allocation; Rats, Wistar; Time Factors; Vasodilation | 2015 |
Regulation of Blood Pressure, Appetite, and Glucose by CNS Melanocortin System in Hyperandrogenemic Female SHR.
Topics: Animals; Appetite; Blood Glucose; Blood Pressure; Body Weight; Central Nervous System; Dihydrotestosterone; Eating; Female; Hyperandrogenism; Insulin; Leptin; Rats, Inbred SHR; Receptor, Melanocortin, Type 3; Receptor, Melanocortin, Type 4; Respiration | 2016 |
20-HETE and CYP4A2 ω-hydroxylase contribute to the elevated blood pressure in hyperandrogenemic female rats.
Topics: Androgens; Animals; Body Weight; Cytochrome P-450 Enzyme System; Dihydrotestosterone; Female; Gene Deletion; Gene Knockout Techniques; Hydroxyeicosatetraenoic Acids; Hyperandrogenism; Hypertension; Microcirculation; Rats; Rats, Inbred Dahl; Renal Circulation; Steroids | 2016 |
Low-Dose Dihydrotestosterone Drives Metabolic Dysfunction via Cytosolic and Nuclear Hepatic Androgen Receptor Mechanisms.
Topics: Animals; Anovulation; Class Ia Phosphatidylinositol 3-Kinase; Cyclic AMP Response Element-Binding Protein; Dihydrotestosterone; Disease Models, Animal; Female; Forkhead Box Protein O1; Gluconeogenesis; Glucose Metabolism Disorders; Hepatocytes; Hyperandrogenism; Insulin Resistance; Liver; Mice, Inbred C57BL; Promoter Regions, Genetic; Receptors, Androgen | 2017 |
Shorter CAG repeats in the androgen receptor gene may enhance hyperandrogenicity in polycystic ovary syndrome.
Topics: Acne Vulgaris; Adult; Alleles; Androgens; Androstenedione; Dihydrotestosterone; Female; Follicle Stimulating Hormone; Hirsutism; Humans; Hyperandrogenism; Luteinizing Hormone; Phenotype; Polycystic Ovary Syndrome; Polymorphism, Genetic; Receptors, Androgen; Trinucleotide Repeats | 2008 |
Altered aquaporin expression in women with polycystic ovary syndrome: hyperandrogenism in follicular fluid inhibits aquaporin-9 in granulosa cells through the phosphatidylinositol 3-kinase pathway.
Topics: Adult; Analysis of Variance; Aquaporins; Blotting, Western; Cells, Cultured; Dihydrotestosterone; Dose-Response Relationship, Drug; Female; Fluorescent Antibody Technique; Follicular Fluid; Granulosa Cells; Humans; Hyperandrogenism; Luteinizing Hormone; Phosphatidylinositol 3-Kinases; Polycystic Ovary Syndrome; Reverse Transcriptase Polymerase Chain Reaction; Sex Hormone-Binding Globulin; Signal Transduction; Testosterone | 2010 |
Determinant role of gonadal sex hormones in the pathogenesis of urolithiasis in a male subject - a document for male predominancy (case study).
Topics: Adult; Dihydrotestosterone; Estradiol; Gonadal Steroid Hormones; Humans; Hyperandrogenism; Male; Sex Hormone-Binding Globulin; Testosterone; Ultrasonography; Urolithiasis | 2010 |
A molecular mechanism underlying ovarian dysfunction of polycystic ovary syndrome: hyperandrogenism induces epigenetic alterations in the granulosa cells.
Topics: Acetylation; Animals; Anti-Mullerian Hormone; Cells, Cultured; Dihydrotestosterone; DNA Methylation; Female; Granulosa Cells; Histone Deacetylases; Humans; Hyperandrogenism; Nuclear Receptor Co-Repressor 1; Polycystic Ovary Syndrome; Polymerase Chain Reaction; Promoter Regions, Genetic; Rats; Rats, Sprague-Dawley | 2012 |
Orphan nuclear receptor NR4A1 is a negative regulator of DHT-induced rat preantral follicular growth.
Topics: Androgens; Animals; Cells, Cultured; Cyclin D2; Dihydrotestosterone; Down-Regulation; Female; Flutamide; Gene Expression; Gene Expression Regulation; Hyperandrogenism; Insulin; Ki-67 Antigen; Nuclear Receptor Subfamily 4, Group A, Member 1; Organ Culture Techniques; Ovarian Follicle; Ovary; Paracrine Communication; Proteins; Rats; Rats, Sprague-Dawley; Receptors, FSH; RNA, Messenger; Transcription, Genetic; Up-Regulation | 2012 |
[Effect of prenatal hyperandrogenism during pregnancy and on postnatal development of rats].
Topics: Androgens; Animals; Dihydrotestosterone; Disease Models, Animal; Embryonic and Fetal Development; Female; Hyperandrogenism; Male; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Prenatal Exposure Delayed Effects; Rats; Rats, Wistar; Reproduction; Sexual Maturation; Testosterone | 2002 |
Frequencies of the D85 and Y85 variants of UGT2B15 in children and adolescent girls with hyperandrogenism.
Topics: Adolescent; Androstane-3,17-diol; Androstenedione; Child; Dihydrotestosterone; Female; Gene Frequency; Genotype; Glucuronosyltransferase; Heterozygote; Homozygote; Humans; Hyperandrogenism; Phenotype; Polycystic Ovary Syndrome; Puberty, Precocious; Sex Hormone-Binding Globulin; Testosterone | 2003 |
Endocrinological markers for assessment of hyperandrogenemia in hirsute women.
Topics: Adult; Androgens; Biomarkers; Dehydroepiandrosterone; Dihydrotestosterone; Female; Hirsutism; Humans; Hyperandrogenism; Reference Values; Sex Hormone-Binding Globulin; Testosterone | 2007 |
[Clinical significance of testosterone and dihydrotestosterone metabolism in women].
Topics: Androgen Antagonists; Dihydrotestosterone; Female; Humans; Hyperandrogenism; Testosterone | 1996 |
[Ovarian function in androgenized rats in puberty].
Topics: Androgens; Animals; Aromatase Inhibitors; Dihydrotestosterone; Female; Gonadal Steroid Hormones; Hyperandrogenism; Ovarian Follicle; Ovary; Ovulation; Rats; Rats, Wistar; Sexual Maturation; Testosterone | 2001 |